|
NUPL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.577500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.938600E-03 |
| Normal-vs-Stage2 |
1.851410E-01 |
| Normal-vs-Stage3 |
2.171200E-04 |
| Normal-vs-Stage4 |
3.024600E-04 |
| Stage1-vs-Stage2 |
8.997400E-01 |
| Stage1-vs-Stage3 |
4.424200E-02 |
| Stage1-vs-Stage4 |
2.878200E-02 |
| Stage2-vs-Stage3 |
1.817030E-01 |
| Stage2-vs-Stage4 |
1.460150E-01 |
| Stage3-vs-Stage4 |
7.395600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.370400E-04 |
| Normal-vs-AfricanAmerican |
8.981400E-03 |
| Normal-vs-Asian |
1.435600E-01 |
| Caucasian-vs-AfricanAmerican |
8.340600E-01 |
| Caucasian-vs-Asian |
2.171400E-01 |
| AfricanAmerican-vs-Asian |
2.691400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.801270E-03 |
| Normal-vs-Female |
1.144560E-03 |
| Male-vs-Female |
6.462600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.959870E-02 |
| Normal-vs-Age(41-60Yrs) |
3.799200E-04 |
| Normal-vs-Age(61-80Yrs) |
4.884800E-03 |
| Normal-vs-Age(81-100Yrs) |
9.956200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.478840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.646800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.709400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.152400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.364600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.930600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.029000E-01 |
| Classical-VS-Follicular |
3.490100E-02 |
| Classical-VS-Other |
5.542600E-01 |
| Classical-VS-Normal |
2.175700E-03 |
| Tall-VS-Follicular |
2.643000E-03 |
| Tall-VS-Other |
3.298800E-01 |
| Tall-VS-Normal |
9.96140000000256E-05 |
| Follicular-VS-Other |
8.002600E-01 |
| Follicular-VS-Normal |
6.080000E-01 |
| Other-VS-Normal |
6.433200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.960600E-03 |
| Normal-vs-N1 |
7.309600E-02 |
| N0-vs-N1 |
7.940400E-01 |
|
|
